NLS Pharmaceutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLSP and other ETFs, options, and stocks.

About NLSP

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. 

CEO
Alexander Zwyer
CEOAlexander Zwyer
Employees
2
Employees2
Headquarters
Zurich, Zurich
HeadquartersZurich, Zurich
Founded
2015
Founded2015
Employees
2
Employees2

NLSP Key Statistics

Market cap
5.72M
Market cap5.72M
Price-Earnings ratio
-0.27
Price-Earnings ratio-0.27
Dividend yield
—
Dividend yield—
Average volume
208.30K
Average volume208.30K
High today
$0.1464
High today$0.1464
Low today
$0.1225
Low today$0.1225
Open price
$0.123
Open price$0.123
Volume
436.93K
Volume436.93K
52 Week high
$1.53
52 Week high$1.53
52 Week low
$0.113
52 Week low$0.113
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.